To the Editors:-We agree with Dr. Bucciarelli-Ducci that cardiovascular magnetic resonance (CMR) is a promising diagnostic test in patients with suspected cardiac involvement from systemic amyloidosis. Maceira 4 It has also been suggested that CMR may be a useful noninvasive means to follow cardiac involvement in amyloid patients after treatment because echocardiography is limited in this regard. 1 Dr. Bucciarelli-Ducci's suggestion of using CMR to target areas for endomyocardial biopsy is also an intriguing application of this technique. As Dr. Bucciarelli-Ducci points out, CMR is not available at all centers as it requires experienced personnel to both administer and interpret the test. While its role has yet to be clearly defined, CMR is likely to become an important part of the armamentarium in the diagnosis and management of cardiac amyloidosis and should be considered as an adjunctive noninvasive test in patients with suspected amyloid myocardial deposition.
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